165 related articles for article (PubMed ID: 27683120)
1. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested.
Ji X; Guan C; Jiang X; Li H
Oncotarget; 2016 Nov; 7(48):80019-80032. PubMed ID: 27683120
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis.
Chen H; Yu Y; Rong S; Wang H
Biomarkers; 2014 May; 19(3):189-97. PubMed ID: 24693860
[TBL] [Abstract][Full Text] [Related]
4. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis.
Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Muinelo-Romay L; Muinelo-Lorenzo J; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204396
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
Zhang M; Zhao LJ; Liang WQ; Mao ZP
Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
Liu W; Ji T; Zhang C; Zhou Q; Bao Z
Oral Oncol; 2022 Nov; 134():106129. PubMed ID: 36202068
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Tang KD; Vasani S; Langton-Lockton J; Kenny L; Punyadeera C
Cells; 2020 May; 9(6):. PubMed ID: 32486347
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer.
Yalniz Z; Demokan S; Suoglu Y; Ulusan M; Dalay N
DNA Cell Biol; 2011 Jan; 30(1):17-24. PubMed ID: 20860434
[TBL] [Abstract][Full Text] [Related]
10. Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.
Juodzbalys G; Kasradze D; Cicciù M; Sudeikis A; Banys L; Galindo-Moreno P; Guobis Z
Cancer Biomark; 2016; 17(4):487-502. PubMed ID: 27802200
[TBL] [Abstract][Full Text] [Related]
11. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J
Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822
[TBL] [Abstract][Full Text] [Related]
12. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.
Cirauqui B; Margelí M; Quiroga V; Quer A; Karachaliou N; Chaib I; Ramírez JL; Muñoz A; Pollán C; Planas I; Drozdowsky A; Rosell R
Tumour Biol; 2016 Oct; 37(10):13435-13443. PubMed ID: 27465548
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
Gross M; Meirovich A; Rachmut J; Kalichman I; Peretz T; Eliashar R; Barak V
Anticancer Res; 2016 Aug; 36(8):4347-52. PubMed ID: 27466555
[TBL] [Abstract][Full Text] [Related]
15. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
Wan J; Wu W; Che Y; Kang N; Zhang R
Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer biomarkers: Systematic review and meta-analysis.
Marakala V
Clin Chim Acta; 2023 Mar; 542():117280. PubMed ID: 36878379
[TBL] [Abstract][Full Text] [Related]
18. Methylation as a biomarker for head and neck cancer.
Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
[TBL] [Abstract][Full Text] [Related]
19. Genetic and proteomic biomarkers of head-and-neck cancer: A systematic review.
Kasradze D; Juodzbalys G; Guobis Z; Gervickas A; Cicciù M
J Cancer Res Ther; 2020; 16(3):410-424. PubMed ID: 32719245
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
